Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the inclusion in this Registration Statement with this amendment No. 1 to Form S-1 (File No. 333-269521) and related Prospectus, of our report dated March 31, 2023, with respect to the consolidated financial statements of Inhibikase Therapeutics, Inc. as of December 31, 2022 and 2021, and for the years then ended.

We also consent to the reference to our firm under the caption “Experts”.

/s/ CohnReznick LLP

Holmdel, New Jersey

March 31, 2023